Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Amy L. Jonson"'
Autor:
Levi S. Downs, Melissa A. Geller, Patricia L. Judson, Thanasak Sueblinvong, Amy L. Jonson, Joseph J. Ivy, Linda F. Carson, Peter A. Argenta
Publikováno v:
Gynecologic Oncology. 129:81-85
We aimed to evaluate the feasibility and tolerability of hyperthermic intraperitoneal carboplatin (HIPEC-carboplatin) following secondary cytoreduction for recurrent, platinum-sensitive ovarian cancer.In a single institution prospective, pilot study,
Autor:
Melissa A. Geller, Rahel G Ghebre, Patricia L. Judson, Peter A. Argenta, Amy L. Jonson, Elizabeth L. Dickson, Linda F. Carson, Levi S. Downs, Yin Xiong
Publikováno v:
Gynecologic Oncology. 123:346-350
Despite increased use of integrative medicine in cancer therapy, little data exist on its efficacy. This prospective, randomized, pilot trial sought to evaluate the feasibility of combined modality integrative medicine (CM-IM) in women with ovarian c
Autor:
David H. McKenna, Levi S. Downs, Rahel G Ghebre, Peter A. Argenta, Amy L. Jonson, Linda F. Carson, Robin L. Bliss, Julie M. Curtsinger, Sarah Cooley, Jeffrey S. Miller, Melissa A. Geller, Angela Panoskaltsis-Mortari, Patricia L. Judson, Kathryn E. Dusenbery
Publikováno v:
Cytotherapy. 13:98-107
Natural killer (NK) cells derived from patients with cancer exhibit diminished cytotoxicity compared with NK cells from healthy individuals. We evaluated the tumor response and in vivo expansion of allogeneic NK cells in recurrent ovarian and breast
Autor:
Rachel Isaksson Vogel, Linda F. Carson, Amy L. Jonson, Levi S. Downs, Peter A. Argenta, Sue V. Petzel, Patricia L. Judson, Kristen Godfrey, Melissa A. Geller, Rahel G Ghebre
Publikováno v:
Gynecologic Oncology. 119:370-375
Objective Effective patient –clinician communication at diagnosis is important, yet decreased provider time for face-to-face interactions makes traditional paradigms in cancer care difficult. We evaluated the effects of an educational video on pati
Autor:
Patricia L. Judson, Levi S. Downs, Sajeena G. Thomas, Amy L. Jonson, Peter A. Argenta, Melissa A. Geller, Rahel G Ghebre, Linda F. Carson
Publikováno v:
Gynecologic Oncology. 113:205-209
Objective. The goal of treating recurrent ovarian cancer is disease control while minimizing toxicity. Fulvestrant, a novel estrogen receptor (ER) antagonist, has proven clinically beneficial and well-tolerated in treating recurrent breast cancer. Ov
Publikováno v:
Gynecologic Oncology. 111:356-364
Objective Selective silencing of HPV oncogenes using short interfering RNA (siRNA) blocks E6/E7 expression and restores normal p53 and Rb function. Our objective was to determine if siRNA targeting E6/E7 would inhibit the growth of established tumors
Autor:
Levi S. Downs, Linda F. Carson, Kathryn E. Dusenbery, Robin L. Bliss, Peter A. Argenta, Alexander M. Truskinovsky, Patricia L. Judson, Amy L. Jonson
Publikováno v:
Gynecologic Oncology. 100:561-564
Background. The objective of this study was to compare the clinical presentation and outcomes of women with ovarian and uterine carcinosarcoma (CS). Methods. We performed a retrospective review of patients treated for uterine or ovarian CS from 1952
Autor:
Amy L. Jonson, Peter A. Argenta, Levi S. Downs, Pamela J. Paley, Robin L. Bliss, Patricia L. Judson, Matthew P. Boente, Karuna P. Murray, Linda F. Carson
Publikováno v:
Gynecologic Oncology. 95:226-230
Based on the reduced morbidity seen in our retrospective study, we undertook a prospective, randomized trial to determine whether transposition of the sartorius muscle improves post-operative morbidity in women with squamous cell carcinoma of the vul
Publikováno v:
Obstetrics & Gynecology. 116:550-552
Gonadal dysgenesis encompasses a variety of sexual differentiation disorders. Within this population of patients, there is an increased risk of gonadal tumor formation.In this case series of three patients, two with Swyer's syndrome (complete gonadal
Autor:
Amy L. Jonson
Publikováno v:
The virtual mentor : VM. 9(1)
A physician explains the human papillomavirus vaccine and guidelines for its use. Virtual Mentor is a monthly bioethics journal published by the American Medical Association.